Analyst Price Targets — A
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 2, 2026 1:47 pm | — | Jefferies | $155.00 | $151.56 | TheFly | Agilent quarterly filing raises questions, says Jefferies |
| August 27, 2026 7:58 pm | — | Wells Fargo | $180.00 | $157.69 | TheFly | Agilent price target raised to $180 from $160 at Wells Fargo |
| August 27, 2026 3:19 pm | Luke Sergott | Barclays | $175.00 | $157.98 | TheFly | Agilent price target raised to $175 from $150 at Barclays |
| August 27, 2026 12:48 pm | — | RBC Capital | $185.00 | $158.78 | TheFly | Agilent price target raised to $185 from $155 at RBC Capital |
| August 27, 2026 12:00 pm | — | RBC Capital | $180.00 | $157.92 | StreetInsider | Agilent (A) PT Raised to $180 at TD Cowen |
| August 27, 2026 11:48 am | Vijay Kumar | Evercore ISI | $172.00 | $155.17 | TheFly | Agilent price target raised to $172 from $148 at Evercore ISI |
| August 27, 2026 11:38 am | — | Bernstein | $180.00 | $155.17 | TheFly | Agilent price target raised to $180 from $155 at Bernstein |
| August 27, 2026 11:13 am | Evie Koslosky | Goldman Sachs | $175.00 | $155.17 | TheFly | Agilent price target raised to $175 from $155 at Goldman Sachs |
| August 27, 2026 10:44 am | Daniel Arias | Stifel Nicolaus | $180.00 | $155.17 | TheFly | Agilent price target raised to $180 from $170 at Stifel |
| July 6, 2026 12:38 pm | Vijay Kumar | Evercore ISI | $148.00 | $128.34 | TheFly | Agilent price target raised to $148 from $144 at Evercore ISI |
Latest News for A
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis. Combining robust engineering, superior performance, and intuitive usability, the Cary 635 FTIR provides laboratories with a powerful solution that enhances reliability, boosts…
INTURAI VENTURES COMPLETES DOMECOMMAND ACQUISITION PR Newswire VANCOUVER, BC, Sept. 1, 2026
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies is upgraded to Buy after a strong Q3 2026, with revenue up 8% and EPS up 18% YoY. All three segments posted robust growth, notably Life Sciences and Diagnostics, which saw operating margin jump nearly 600 bps to 23.5%. Guidance for Q4 and FY26 implies continued momentum, with management projecting 6.5–7.5% revenue growth and 8.5% EPS growth for Q4.
Agilent Technologies, Inc. (A) Q3 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.